CVSA
Covista Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-15 | Manning Amelia |
President, Chamberlain Univ. |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in two equal installments beginning on July 15, 2027. |
Common Stock
|
4,317 |
| 2026-07-13 | Beard, Stephen W. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $130.6625 to $134.02. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
5,291 |
| 2026-07-08 | Phelan Robert J. |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $135.00 to $135.71. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
2,414 |
| 2026-07-08 | BECK DOUGLAS G. |
EVP Secretary, General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $135.00 to $135.56. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
2,439 |
| 2026-07-07 | BECK DOUGLAS G. |
EVP Secretary, General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $135.00 to $135.63. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
2,650 |
| 2026-07-07 | Phelan Robert J. |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $135.00 to $135.59. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
2,900 |
| 2026-06-11 | Beard, Stephen W. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $130.26 to $131.465. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
2,529 |
| 2026-06-10 | Beard, Stephen W. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $130.02 to $130.39. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
2,762 |
| 2026-05-18 | Gangadharan Manjunath |
VP, Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
426 |
| 2026-05-18 | Manning Amelia |
President, Chamberlain Univ. |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-08 | BECK DOUGLAS G. |
EVP Secretary, General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $125.00 to $128.20. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
9,615 |
| 2026-05-08 | Phelan Robert J. |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $125.00 to $128.09. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
10,000 |
| 2026-05-08 | Beard, Stephen W. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $130.00 to $132.67. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
15,874 |
| 2026-05-08 | Cox Karen Sue |
President, Chamberlain Univ. |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception. This transaction was executed in multiple trades at prices ranging from $124.00 to $125.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
2,000 |
| 2026-04-15 | Liles Scott |
President, Medical and Vet |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
448 |
| 2026-03-11 | MALAFRONTE MICHAEL W |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The reported securities are held by an irrevocable trust of which the reporting person serves as a trustee. This transaction was executed in multiple trades at prices ranging from $100.58 to $101.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
8,890 |
| 2026-03-10 | MALAFRONTE MICHAEL W |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The reported securities are held by an irrevocable trust of which the reporting person serves as a trustee. This transaction was executed in multiple trades at prices ranging from $99.51 to $102.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
15,305 |
| 2026-03-10 | MALAFRONTE MICHAEL W |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $99.51 to $102.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
11,841 |
| 2026-03-03 | MALAFRONTE MICHAEL W |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The reported securities are held by an irrevocable trust of which the reporting person serves as a trustee. This transaction was executed in multiple trades at prices ranging from $97.87 to $98.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
1,200 |
| 2025-12-10 | Beard, Stephen W. |
Director |
Gift↓
Filing footnotes — Common Stock (Direct)
This reported transaction was a gift from Mr. Beard to a Charitable Donor-Advised Fund. |
Common Stock
|
5,332 |
| 2025-11-13 | Phelan Kenneth J |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
392 |
| 2025-11-13 | MALAFRONTE MICHAEL W |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
526 |
| 2025-11-13 | Kiser Georgette D. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
425 |
| 2025-11-13 | Betz Michael |
Pres. Walden University & CDO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
441 |
| 2025-11-13 | Beard, Stephen W. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
9,204 |
| 2025-11-13 | Herrera Maurice |
SVP - Chief Marketing Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
343 |
| 2025-11-13 | Krehbiel William V |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
421 |
| 2025-11-13 | BURKE WILLIAM W |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
390 |
| 2025-11-13 | Phelan Robert J. |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
623 |
| 2025-11-13 | Cox Karen Sue |
President, Chamberlain Univ. |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
310 |
| 2025-11-13 | Trent Evan |
President, Adtalem Elevate |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
355 |
| 2025-11-13 | BECK DOUGLAS G. |
EVP Secretary, General Counsel |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
361 |
| 2025-11-13 | Hrinak Donna J |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
344 |
| 2025-11-13 | WARDELL LISA W |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
645 |
| 2025-11-13 | Gangadharan Manjunath |
VP, Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
94 |
| 2025-11-13 | Vandenbosch Betty M. |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
421 |
| 2025-11-13 | Liles Scott |
President, Medical and Vet |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Common Stock
|
407 |
| 2025-11-12 | Vandenbosch Betty M. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025. |
Common Stock
|
1,445 |
| 2025-11-12 | Liles Scott |
President, Medical and Vet |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. |
Common Stock
|
2,613 |
| 2025-11-12 | O'KEEFE SHARON |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025. |
Common Stock
|
1,445 |
| 2025-11-12 | MALAFRONTE MICHAEL W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025. |
Common Stock
|
1,445 |
| 2025-11-12 | BURKE WILLIAM W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025. |
Common Stock
|
1,445 |
| 2025-11-12 | Gangadharan Manjunath |
VP, Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. |
Common Stock
|
890 |
| 2025-11-12 | Hrinak Donna J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025. |
Common Stock
|
1,445 |
| 2025-11-12 | Herrera Maurice |
SVP - Chief Marketing Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. |
Common Stock
|
1,750 |
| 2025-11-12 | Betz Michael |
Pres. Walden University & CDO |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. |
Common Stock
|
5,575 |
| 2025-11-12 | Trent Evan |
President, Adtalem Elevate |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. |
Common Stock
|
1,673 |
| 2025-11-12 | WARDELL LISA W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025. |
Common Stock
|
1,445 |
| 2025-11-12 | Phelan Robert J. |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. |
Common Stock
|
4,259 |
| 2025-11-12 | BECK DOUGLAS G. |
EVP Secretary, General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. |
Common Stock
|
2,075 |